Watch out—momentum stocks are out of favor


Crispr Therapeutics AG: “Here’s the problem: that’s a momentum stock, and right now, momentum is out of favor so I cannot necessarily recommend that Crispr is the place to be.”

Camping World Holdings: “I think it trades with Thor, frankly, whether it should or not, and Thor hit another 52-week low today, so I am going to say not yet, not yet, not yet.”

Spectrum Pharmaceuticals: “No, man. If you’re going to do that, you want to go high end. I want you [in] Amgen, which my charitable trust owns. Amgen’s got this drug, Aimovig, which is taking the world by storm. It’s an anti-migraine drug. Amgen is the one you want.”

Avangrid Inc.: “All the utility stocks are going down. The two I’m recommending are Dominion now that it’s finishing up the South Carolina situation, but more importantly, AEP.”

Source link

Products You May Like

Articles You May Like

OCBC CEO Samuel Tsien on earnings, China slowdown impact on bank loans
Your first trade for Wednesday, February 20
From stock picking to educating
Domino’s shares slide after same-store sales growth disappoints
Move to a nearby town

Leave a Reply

Your email address will not be published. Required fields are marked *